SUMMARY
Mycobacterium tuberculosis (Mtb) can survive in hypoxic necrotic tissue by assimilating energy from host-derived fatty acids. While the expanded repertoire of b-oxidation auxiliary enzymes is considered crucial for Mtb adaptability, delineating their functional relevance has been challenging. Here, we show that the Mtb fatty acid degradation (FadAB) complex cannot selectively break down cis fatty acyl substrates. We demonstrate that the stereoselective binding of fatty acyl substrates in the Mtb FadB pocket is due to the steric hindrance from Phe287 residue. By developing a functional screen, we classify the family of Mtb Ech proteins as monofunctional or bifunctional enzymes, three of which complement the FadAB complex to degrade cis fatty acids. Crystal structure determination of two cisINTRODUCTION Tuberculosis (TB) continues to be among the leading causes of infectious disease mortality. The primary causative organism, Mycobacterium tuberculosis (Mtb), is believed to exhibit a spectrum of metabolic states leading to heterogeneity and differential drug sensitivity (Barry et al., 2009; Wakamoto et al., 2013) . Along with glucose (Marrero et al., 2013) , an intriguing feature that has emerged is the intracellular adaptability of tubercle bacilli to also utilize host fatty acids and lipids as a carbon source (Griffin et al., 2012; Lee et al., 2013; McKinney et al., 2000; Pandey and Sassetti, 2008) . Such strategic rewiring is proposed to trigger a dormancy switch with decreased growth rate, accumulation of lipid bodies, and development of drug-tolerant bacilli (Daniel et al., 2011) . Interestingly, Mtb in cultures simultaneously assimilate multiple carbon sources to achieve enhanced monophasic growth (de Carvalho et al., 2010) , in contrast to other bacterial systems in which carbon sources are used in a preferential order. While the Mtb genome possesses an unusually rich repository of lipid-remodeling enzymes (Cole et al., 1998) , our understanding of the metabolic activity in the lipid-rich environment during this complex period of latency is very limited.
Lipid degradation requires a variety of hydrolases and lipases that release fatty acyl chains, which are then broken down to acetyl coenzyme A (CoA) building blocks by the b-oxidation machinery that consists of five core catalytic functions. This pathway was first characterized in Escherichia coli as the FAD (fatty acid degradation) operon, and is conserved in all living organisms (Black and DiRusso, 1994) . Conversion of a fatty acid to its corresponding fatty acyl CoA by FadD (acyl CoA synthetase) initiates the process, which is then acted upon by FadE (acyl CoA dehydrogenase) to generate unsaturation at the a,b position. Enoyl CoA hydratase (ECH) hydroxylates the carbon chain at the b position that is further converted to a keto group by 3-hydroxyacyl CoA dehydrogenase (HACD). The ECH and the HACD activity are often catalyzed by the multifunctional protein FadB. Finally, a ketothiolase FadA reduces the fatty acyl chain by two carbon units with the release of acetyl CoA. While this enzyme system is sufficient to catabolize saturated fatty acids, unsaturation requires an additional catalytic step involving repositioning of the double bond to acquire a trans configuration at the a,b position. For example, oleic acid degradation after three rounds of b-oxidation results in the formation of an intermediate 3-cis dodecenoyl CoA that has to be isomerized to 2-trans dodecenoyl CoA. This activity in E. coli and Pseudomonas fragi is embedded within the multifunctional enzyme FadB (Imamura et al., 1990; Pramanik et al., 1979) . Higher organisms such as yeast, rat, and humans possess stand-alone monofunctional 3-cis 2-trans enoyl CoA isomerases (ECI) (Geisbrecht et al., 1999; Gurvitz et al., 1998; Zhang et al., 2002) . The Mtb genome contains more than 100 proteins with homology to such b-oxidation enzymes, which makes it incredibly challenging to elucidate their specific biochemical functions (Cole et al., 1998; Gokhale et al., 2007) .
In vitro growth of Mtb is best suited in a medium that contains glucose and glycerol as the primary carbon sources. However, Chemistry & Biology 22, 1-11, December 17, 2015 ª2015 Elsevier Ltd All rights reserved 1 several studies propose a distinctive growth advantage on addition of long-chain fatty acids; therefore, oleic acid is often used as a supplement in the classic Middlebrook medium (Dubos and Davis, 1946; Schaefer and Lewis, 1965) . Such fatty acyl chains are the constituents of host lipids, and triacylglycerol lipid assimilation by mycobacteria is anticipated to proceed through the b-oxidation pathway. The Mtb prototype FadAB multienzyme complex is analogous to the E. coli system, and recent structural and biochemical studies provided insights into this evolutionarily conserved enzyme function (Venkatesan and Wierenga, 2013) . This study examined degradation of saturated fatty acids; however, it is not clear whether the Mtb FadAB complex can break down unsaturated fatty acids. Previous studies with Mtb b-oxidation enzymes have provided novel themes in lipid metabolism. For example, among the 34 FadD homologs, a new family of FAALs involved in lipid biosynthesis were identified (Trivedi et al., 2004; Arora et al., 2009; Simeone et al., 2010; Vergnolle et al., 2013 ). An enzymatic system consisting of FadD3, FadE27, and FadE28 were identified to be involved in cholesterol degradation (Casabon et al., 2013; Thomas and Sampson, 2013) . Similarly, FadE14 was shown to be involved in biosynthesis of the acyl chain of mycobactin (Krithika et al., 2006) . The Mtb genome contains approximately 21 Ech homologs that are expected to function as enoyl CoA hydratase/isomerases (ECH/I) (Cole et al., 1998 ). The TraSH screen had indicated essentiality of echA5 for in vitro growth of Mtb (Sassetti et al., 2003) ; however, subsequent studies showed no in vitro or in vivo growth defects (Williams et al., 2011) . The role of echA9 has been suggested in cholesterol assimilation, although the exact biochemical function is unknown (Griffin et al., 2011) .
Given the importance of lipids as the energy source of Mtb and the predominance of unsaturated fatty acyl chains in eukaryotic lipids, we set about elucidating mycobacterial machinery involved in assimilation of these fatty acids. We show that Mtb FadB cannot specifically degrade cis fatty acids, and requires additional proteins to derive energy from such carbon sources. Structural and mutagenic studies reveal Phe287 as the ''gatekeeper'' residue blocking the utilization of cis substrates. Biochemical and genetic complementation studies identify three Ech proteins, which assist the FadAB complex to degrade cis fatty acids. Furthermore, we solve the structure for two of the cis-trans ECI that provide a mechanistic basis underlying monofunctional and bifunctional catalytic activity for Ech proteins.
RESULTS

Mtb FadA1B1 Proteins Can Complement E. coli Lauric Acid Auxotroph Strain
The Mtb genome encodes for a FadA1B1 (FadAB) enzymatic system, which is analogous to the prototype E. coli FadAB multifunctional complex. While there are five other FadA homologs annotated as FadA2 to FadA6 in Mtb, only a functional role for FadA5 has been proposed, which exists in cholesterol degradation (Nesbitt et al., 2010) . Annotation of the Mtb genome has suggested two FadB homologs, FadB2 and FadB3. However, both are approximately half the size of multifunctional FadB and they align to the C-terminal region known to code for HACD activity (Taylor et al., 2010) . Earlier biochemical studies with Mtb FadAB revealed that this heterotetrameric complex contains ketothiolase, ECH, and HACD functions (Venkatesan and Wierenga, 2013) . To study FadAB, we first developed an E. colibased genetic complementation screen whereby the gain of function could be exploited to establish biochemical function ( Figure 1A) . In this approach, we disrupted E. coli fadAB in the BL21 background resulting in a strain (DfadAB E. coli) that was auxotrophic for growth on fatty acid ( Figure S1 ). This strain, however, showed no growth defects on glucose or acetate as carbon sources. The plasmid-based expression of E. coli fadAB (fadAB E.coli ) rescued the fatty acid growth phenotype on minimal media containing laurate and could be detected by a clearing zone on the plate ( Figure 1B ). Sodium laurate-containing agar plates were turbid due to incomplete solubility of the fatty acid in minimal agar; hence, utilization of this fatty acid for growth led to a clearing zone. We then examined whether Mtb fadAB (fadAB Mtb ) could also complement DfadAB E. coli for its growth on lauric acid. The coexpression of fadAB Mtb indeed rescued the growth phenotype, thus indicating that fadAB Mtb is similar to fadAB E.coli . The genetic complementation assays were performed in the absence of an inducing agent, since Mtb FadA is primarily expressed in inclusion body at 37 C if overexpressed with isopropyl b-D-1-thiogalactopyranoside. As the leaky protein expression was sufficient to overcome the growth defect, all further studies were performed under these conditions. This complementation by Mtb proteins also suggested that other enzymes from the E. coli b-oxidation pathway can cooperate with fadAB Mtb for fatty acid assimilation. Furthermore, we performed in vitro enzymatic assay with purified Mtb FadAB complex using crotonyl CoA as a substrate. The reaction mixture was analyzed by mass spectrometry (MS). A doubly charged peak [M À H] À2 of 403.5 corresponding to the product acetyl CoA was detected ( Figure 1C ), thus confirming the Mtb FadB ECH and HACD activity and FadA ketothiolase function as reported earlier.
E. coli with Mtb FadAB Cannot Degrade cis-Unsaturated Fatty Acid
We then examined whether Mtb FadAB could degrade oleic acid as the sole carbon source for its growth by using the E. coli genetic complementation screen. While we observed robust growth on the oleic acid minimal medium plates for the fadAB E.coli complementation, fadAB Mtb could not restore the growth of DfadAB E. coli strain (Figure 2A) . Since E. coli FadB is known to isomerize 3-cis dodecenoyl CoA to 2-trans dodecenoyl CoA that is required for oleic acid utilization, we reasoned that the inability of fadAB Mtb to complement could be due to the absence of similar isomerase activity for Mtb FadB. We therefore set up an in vitro enzymatic assay to examine differences between Mtb and E. coli FadB proteins. We synthesized 3-cis octenoyl CoA and 3-trans octenoyl CoA and standardized enzymatic assays by using E. coli FadB ( Figure S2A ). Formation of product was followed by high-performance liquid chromatography (HPLC) coupled with MS analysis. The two substrates eluted at slightly different retention times of 18.4 and 19.4 min with identical mass m/z of 891.71 Da in the negative ion mode ( Figure S2C ). The product eluted at 12.2 min with m/z of 908.21 Da, corresponding to 3-hydroxyoctanoyl CoA ( Figure S2B ). As ECI catalyze the conversion of both 3-cis and 3-trans to 2-trans enoyl CoA, E. coli FadB could isomerize both cis and trans substrates and convert them to the hydroxylated product. A similar enzymatic assay with Mtb FadB using the 3-trans substrate resulted in the formation of the hydroxylated product and a new peak eluting very close to the substrate peak, which may correspond to the intermediate 2-trans octenoyl CoA ( Figure 2B ). Upon increasing the reaction incubation time, however, the substrate peak reduced and only this small peak was observed. Formation of the hydroxylated product was not seen with 3-cis octenoyl CoA, demonstrating that Mtb FadB is unable to utilize 3-cis substrates ( Figure 2B) . A small peak could be observed at elution time 12.2 min for the 3-cis substrate assay, which may correspond to the minor contamination of the trans isomer ( Figure 2C ). These results thus indicate that Mtb FadB cannot convert 3-cis to 2-trans enoyl CoA.
The Mtb genome encodes for 21 Ech homologs, which could provide the required 3-cis 2-trans ECI function. The monofunctional ECI are not functionally characterized from bacterial systems and are only known from peroxisome and mitochondria in eukaryotes (Zhang et al., 2002 purified yeast peroxisomal Eci1 from E. coli (Geisbrecht et al., 1998) . Incubation of the purified yeast protein with the 3-cis substrate resulted in a peak at 20.1 min ( Figure 2D ). This product peak has mass identical to that of the substrate and corresponds to the thermodynamically stable synthetic 2-trans octenoyl CoA (Figure S2C ). The purified protein was then included in the Mtb FadB in vitro assay. Remarkably, 3-cis octenoyl CoA substrate could now be completely converted to 3-hydroxyoctanoyl CoA ( Figure 2D ). This biochemical complementation could be replicated in the E. coli-based genetic screen, and fadAB Mtb along with yeast peroxisomal monofunctional Eci1 showed robust growth on oleic acid ( Figure 2E ). Our studies thus demonstrate that Mtb FadB protein lacks the 3-cis to 2-trans isomerization function.
Role of Phe287 as ''Steric Gate'' In contrast to E. coli and Pseudomonas FadB, Mtb FadB showed stereoselective ability to catalyze the 3-trans 2-trans ECI function. Conversion of 3-trans to 2-trans enoyl CoA by Mtb FadB requires bond migration, and conversion of 3-cis to 2-trans enoyl CoA would additionally involve a change in stereochemistry. This stereoselective mode of catalysis could be a consequence of the absence of a key catalytic residue in the Mtb FadB protein, or due to inappropriate binding of cis substrate to the protein active site. Structural analysis of Mtb FadB with Pseudomonas FadB (PDB: 1WDK) showed conservation of the active-site Glu residue (Ishikawa et al., 2004) . Since the structure of Mtb FadB was solved with CoA at the catalytic pocket (Venkatesan and Wierenga, 2013) , we modeled the 3-trans and 3-cis fatty acyl chains. We generated FadB-bound structures for both 3-trans and 3-cis octenoyl CoA using molecular docking, allowing flexible orientation of ligands to position in an a priori active site. While we observed that the trans substrate fitted well within the catalytic pocket, the cis substrate could not be accommodated in the substrate binding cavity ( Figures 3A and 3B ). Careful analysis identified the role of three amino acid residues that may be involved in restricting the binding of the cis fatty acyl chain. While hydrophobic residues V88 and I91 were present on one face of the binding pocket, F287 occupied the other face of the pocket ( Figure 3B ). We therefore generated two mutants, V88A/I91A and F287A, of Mtb FadB protein. Upon purification of these mutant proteins from soluble fraction, gel-filtration analysis was performed. While Mtb FadB F287A mutant elutes as a monomer similar to that of the wildtype Mtb FadB, Mtb FadB V88A/I91A mutant forms soluble aggregates and elutes in the void volume ( Figure S3 ), indicating that these residues may be required to maintain a proper protein scaffold. Biochemical assay performed using the 3-cis octenoyl CoA substrate showed, remarkably, that Mtb FadBF287A converted 3-cis octenoyl CoA to 3-hydroxyoctanoyl CoA in the absence of stand-alone ECI ( Figure 3C ). Our studies thus propose that F287 causes steric hindrance and inhibits the binding of the cis fatty acyl chain in the catalytic cavity. This gain of function could also be validated by the genetic complementation in the E. coli model system, whereby F287A mutant of Mtb FadB can efficiently utilize oleate for its growth ( Figure 3D ). 
Search for 3-cis 2-trans ECI in Mtb
The E. coli multifunctional FadB protein contains four different catalytic functions (Pramanik et al., 1979) . The C-terminal region is shown to catalyze HACD activity, whereas ECH, ECI, and epimerase functions are embedded within the N-terminal region, which adopts a typical crotonase fold. The Mtb genome encodes 21 Ech homologs that show homology with the N-terminal region of FadB. At present it is not feasible to assign functions for such stand-alone proteins due to the lack of precise understanding of the sequence-function relationship. To identify the enzyme that would be involved in the degradation of cis fatty acyl chains, we cloned, expressed, and purified all Mtb Ech proteins in E. coli ( Figure 4A ). EchA3, echA12, and echA18 did not express while echA13 showed very poor expression in the heterologous host. We then performed enzymatic assays with the purified Ech proteins in the presence and absence of Mtb FadB. In the absence of Mtb FadB, the formation of hydroxylated product was observed in EchA1, EchA8, and EchA9 (Figures 4B and S4) . This shows that all of these three proteins are in fact bifunctional and can convert 3-cis to 2-trans octenoyl CoA and further carry out hydration to yield 3-hydroxyoctanoyl CoA. In contrast, EchA2, EchA5, EchA10, EchA11, and EchA16 could only isomerize 3-cis to 2-trans octenoyl CoA and required FadB to produce 3-hydroxyoctanoyl CoA ( Figures 4C and S5 ). These five homologs could be considered as monofunctional ECI that primarily contain 3-cis 2-trans ECI function. In addition, we performed a biochemical assay with the Mtb EchA12 homolog from Mycobacterium smegmatis (Msmeg_3139) and found it to be monofunctional 3-cis 2-trans ECI ( Figure S5E ). Other Mtb Ech proteins; EchA4, EchA6, EchA7, EchA14, EchA15, EchA17, EchA19, EchA20, and EchA21, did not show ECI or ECH activity with 3-cis octenoyl CoA and may possess different substrate specificity. Finally, we used our genetic complementation strategy to identify the cognate ECI, which can function in vivo along with fadAB Mtb to assimilate oleic acid. Coexpression of echA1, echA5, and echA10 showed robust growth on oleic acid-supplemented media ( Figure 4D ). Together, genetic and biochemical studies reveal the remarkable redundancy of these enzymes in the Mtb genome and broadly classify Ech proteins as monofunctional and bifunctional proteins.
To provide further evidence for their role in degrading oleic acid in Mtb, we adapted Mtb H37Rv to grow with oleate as the major carbon source (0.1 g/100 ml). Under these conditions, tubercule bacilli could grow up to mid-log phase. We compared the expression profiles of all ech, fadA and fadB genes. Along with fadA1 and fadB1, echA1, echA4, and echA5 showed significant transcriptional upregulation in the oleic acid conditioned strain ( Figure 4E ). These studies thus identify the cognate Mtb enzymes that may be involved in the degradation of oleic acid.
Analysis of Mtb Ech Proteins
The 21 homologs of Ech in Mtb provide an opportunity to delineate the complexity of the sequence-function relationship among the crotonase superfamily. Structural and mutagenic studies have revealed several interesting enzymatic features of these proteins, and both hydration and isomerization is attributed to the presence of Glu residues in the active site (MullerNewen et al., 1995) . Bifunctional ECH/I enzyme contains two Glu in the same active site while the monofunctional ECI contain only one Glu residue (Kiema et al., 1999) . Previous studies with mitochondrial and peroxisomal monofunctional ECI have revealed active-site Glu residue at position Glu165 and Glu158, respectively (Muller-Newen and Stoffel, 1993; Mursula et al., 2001 ). Sequence ( Figure 5A ) and structure-based alignments ( Figure 5B) of mitochondrial (PDB: 1XX4 and 1SG4) and peroxisomal (PDB: 1HNU and 2F6Q) enzyme with rat bifunctional enzymes (PDB: 2DUB) show that the active-site Glu residues are present at spatially distinct positions (Hubbard et al., 2005; Mursula et al., 2001; Partanen et al., 2004) . While the mitochondrial active-site Glu residue (position II, shown in pink, Figure 5B ) align with one of the Glu of the bifunctional enzyme (shown in blue, Figure 5B ), the peroxisomal Glu active-site residue is distinctly positioned (position III in green, Figure 5B ). We mapped out the active-site residues for Mtb Ech proteins by performing comparative analyses with these three proteins ( Figure S6A ). Of the eight proteins for which we could assign function, three showed bifunctional activity. EchA1 and EchA8 contained two Glu residues at positions I and II, analogous to rat bifunctional protein ( Figure 5C ). EchA9 contains Glu at position II and, surprisingly, Asp at Position III. All proteins with monofunctional activity contained only one acidic residue. EchA5 and EchA16 has Glu at position I; EchA2 has Asp at position I; and EchA10 and EchA11 contain Asp at position III. The presence of an Asp residue at the active site in Mtb proteins is rather unusual and has been recently proposed to be the catalytic residue for the ECI PaaF function in the phenylacetic acid degradation pathway (Grishin et al., 2012) . Since position I is unusual for ECI proteins, we confirmed our proposition by performing site-directed mutagenesis and also by solving the structure of this protein to locate the active site (described in the next section). Based on this analysis, we propose that either of the three positions could be used by Ech proteins to catalyze enzymatic functions and that the monofunctional/bifunctional activity can be predicted based on the number of acidic residues. It is interesting that in Mtb Ech proteins, Glu has been replaced by Asp in several enzymes. In the bottom panel of Figure 5C , we predict active-site residues and biochemical function for these proteins. Only protein EchA19 contains two acidic residues, whereas the protein EchA21 contains acidic residues at all three positions. Such active-site residues are reported for rat mitochondrial dienoyl CoA isomerase (DCI) (Modis et al., 1998) . It is tempting to speculate that EchA21 could be an Mtb homolog for a DCI. (red) and Mtb FadB (black) using 3-cis octenoyl CoA as substrate. 1: 3-cis octenoyl CoA; 2: 2-trans octenoyl CoA; 3: 3-hydroxyoctanoyl CoA (see also Figure S4 ). (C) HPLC chromatogram overlay for biochemical activity of Mtb EchA5 (red), Mtb FadB (black), and Mtb EchA5 along with Mtb FadB (blue) using 3-cis octenoyl CoA as substrate. 1: 3-cis octenoyl CoA; 2: 2-trans octenoyl CoA; 3: 3-hydroxyoctanoyl CoA (see also Figure S5 
Structure of ECI from Mycobacteria
To further confirm our predictions, we solved the crystal structure for two monofunctional ECI proteins; Mtb EchA5 which contains Glu residue at position I, and Msmeg_3139 in which Glu residue occupies position III. The structure of Mtb EchA5 and Msmeg_3139 were solved to a resolution of 1.97 and 2.06 Å with P3121 and R32 space groups, respectively. The crystallographic data collection and refinement statistics are given in Figure S6B . The loop regions 68-92 and 144-146, and C-terminal region 241-273 of Msmeg_3139 show poorly defined electron density and hence has not been modeled. Despite weak sequence similarity, as observed within members of the crotonase superfamily, crystal structures of Msmeg_3139 and Mtb EchA5 exhibit the characteristic twodomain architecture with a large N-terminal domain and a small C-terminal domain. The N-terminal domain is composed of 209 and 196 residues in Msmeg_3139 and EchA5, respectively, while the C-terminal domain is made up of 70 and 76 residues in Msmeg_3139 and EchA5, respectively. The N-terminal domain is an a/b domain and contains repeating bba units that assemble into two approximately perpendicular b sheets surrounded by a helices, which forms the crotonase fold ( Figures 6A and 6B ). The C-terminal domain facilitates the oligomerization as seen with many other members of the crotonase superfamily. The C-terminal domain of Msmeg_3139 and Mtb EchA5 is chiefly involved in intra-trimer associations, burying about 13%-14% of the surface area and forming a V-shaped trimer. Both Msmeg_3139 and Mtb EchA5 assemble into dimers of trimers facilitated by the inter-trimer interactions.
To identify the catalytic residue, we performed a structural overlay of EchA5 and Msmeg_3139 with the well-characterized ECI structures in the PDB. The substrate binding pocket of these ECI was mapped by structural overlay with the ligand bound rat crotonase (PDB: 2DUB). Both Mtb EchA5 and Msmeg_3139 contain only one Glu residue in the catalytic pocket. Our analysis suggested that Glu110 of Mtb EchA5 is the probable catalytic residue ( Figure 6C ). Structural overlay of Msmeg_3139 with yeast peroxisomal ECI (PDB: 1HNU) suggested that Glu152 is the probable active-site residue (Figure 6D) . We further mapped out all the other nearby Glu residues (E121 and E122) present in the primary sequence of EchA5 on the structure, and found that these were facing away from the substrate binding pocket ( Figure S6C ). Furthermore, to validate our analysis we generated an Mtb EchA5 E110A mutant by site-directed mutagenesis. The stability of the mutant protein was confirmed by gel filtration ( Figure S6D ). The ECI function of EchA5 E110A mutant was lost, demonstrating E110 to be a critical residue for its function ( Figure 6E ). Taken together, these studies substantiate our hypothesis that the position of acidic residues in the catalytic pocket determines the biochemical function. Figure S6 ).
DISCUSSION
Lipid metabolism in mycobacteria has been the focus of attention for several decades. Studies with unusual lipidic components of the Mtb cell envelope has led to several new paradigms, from the perspective of both novel structures and new pathways of biosynthesis (Brennan, 2003; Gokhale et al., 2007; Kolattukudy et al., 1997; Passemar et al., 2014) . While lipids are recognized to be an alternative source of energy for Mtb survival in vivo, the enzymatic machinery involved in fatty acid assimilation is poorly characterized. Cholesterol degradation by Mtb was recently shown to provide acetyl CoA, propinoyl CoA, and pyruvate precursors (Griffin et al., 2012) . However, the lipolytic system that can break down the major constituents of host lipids, diacylglycerol and triacylglycerol, has yet to be elucidated. Since (Venkatesan and Wierenga, 2013) . We recapitulated this activity in the genetic reconstitution assays, whereby E. coli auxotrophic strain (DfadAB E. coli) was complemented with FadAB either from E. coli or Mtb for its growth on lauric acid. Mtb proteins showed 80% of the growth compared with E. coli, suggesting that Mtb proteins can efficiently coordinate with other b-oxidation enzymes (FadD and FadE). However, the Mtb FadAB complemented strain could not catabolize cis fatty acids such as oleic acid. The underlying chemistry of fatty acid degradation requires a trans double bond at the a,b position. The classical degradation of oleic acid would require an isomerization activity that converts the 3-cis dodecenoyl CoA to 2-trans dodecenoyl CoA. This activity has been previously reported to be carried out by E. coli FadB protein, and we therefore reasoned that Mtb FadB may lack this crucial 3-cis 2-trans ECI function. Biochemical assays indeed supported this argument and showed a lack of 3-cis to 2-trans activity, although the same enzyme was able to catalyze 3-trans to 2-trans isomerization. cis double bonds introduce kinks in the fatty acid chain, and our computational docking studies suggested unfavorable steric contacts with the side chain of F287 in the active-site pocket. Mutant F287A Mtb FadB catalyzed the 3-cis to 2-trans activity and also restored oleic acid-mediated growth phenotype in the complementation assays. Surprisingly, this Phe residue is conserved in E. coli and P. fragi FadB proteins, both of which possess 3-cis 2-trans ECI function. A possible explanation could be the differences in the active-site cavity volumes of the three proteins. The Mtb FadB pocket of 256 Å 3 is approximately half that of P. fragi (423 Å 3 ) (Oliveira et al., 2014) . The Phe to Ala change expands the volume by 22% (314 Å 3 ), and therefore can accommodate the kinked cis substrates.
In several eukaryotes, the 3-cis to 2-trans conversion is carried out by stand-alone proteins ECI. Mtb genome encodes for 21 putative homologs, and we investigated the ECI activity of all of these proteins. Biochemical assays with purified proteins showed ECI activity for five Mtb Ech proteins, whereas three of them catalyzed both ECI and ECH activity for octenoyl CoA substrate. Other Ech homologs showed no activity with straightchain fatty acids, and may have specificity for aromatic or more complex lipids (Grishin et al., 2012) . Complementation of only three Mtb Ech with Mtb FadAB restored the growth of E. coli fatty acid auxotroph on oleic acid. It is pertinent to note that Ech proteins have to perform their function during a specific cycle of iterative catalysis, and this lack of in vivo complementation could be due to inefficient interaction with FadAB proteins. This requirement of stand-alone isomerase was substantiated in Mtb by demonstrating upregulation of genes (fadA, FadB, echA1, echA4, and echA5) in oleic acid-adapted Mtb strain. Our studies suggest that EchA5 could be the prominent monofunctional ECI for degradation of oleic acid.
The monofunctional (ECI) and bifunctional (ECH/I) activity for this family of proteins have been previously attributed to the number of Glu residues in the active site, one for ECI and two for ECH/I (Kiema et al., 1999; Muller-Newen et al., 1995; Muller-Newen and Stoffel, 1993; Mursula et al., 2001 ). Surprisingly, EchA5 lacked conserved Glu residue at either of these two positions. Three-dimensional structural elucidation suggested another Glu residue (position I in Figure 4C ) in the active site, which was supported by mutagenic studies. Based on analysis of 21 homologs, we therefore propose that the active Glu residue could occupy any of the three positions in the active site ( Figure 4C ), and subtle differences in the positioning of substrates compensates for these discrete Glu geometry in the active site. Sequence analysis of all three positions also suggests that some of the Glu residues are replaced by another acidic residue, Asp. Future studies should investigate the role of these Asp residues as well as understand the evolution of monofunctional and bifunctional proteins. In a previous study, Asp residue was implicated for the PaaF protein, which is involved in phenylacetic acid degradation (Grishin et al., 2012) .
Our studies show that cis-trans isomerase could be of great significance to Mtb for its survival in lipid-rich environments. Such a transition can dramatically alter the fluidity of membranes. Recent studies have revealed the role of functional lipid domains in cellular signaling (Heipieper et al., 2003; Raghupathy et al., 2015) . It may be interesting in future to examine whether some of the other Mtb Ech homologs may be affecting membrane fluidity in adapting to changing environmental conditions.
SIGNIFICANCE
Approximately 8-9 million new cases of TB are reported annually, with about 1.5 million deaths. Part of the problem with treating TB is the latent infection of the causative agent, Mtb, and the emergence of new drug-resistant strains. During latency, Mtb probably survives in unusual hideouts by utilizing diverse adaptive strategies, including utilization of host lipids as another source of deriving energy. In this study, we delineate the Mtb enzymatic machinery involved in assimilation of cis-unsaturated fatty acids, the key constituents of storage lipids. We show that the prototype fatty acid degradation enzyme complex FadAB cannot completely break down cis fatty acids due to the steric obstruction by residue Phe287. Our study identifies a family of enoyl CoA isomerases (Ech) from Mtb that complement FadAB in the degradation of cis fatty acids. Furthermore, based on the structural elucidation of Ech proteins, we classify 21 Mtb homologs as monofunctional or bifunctional enzymes. Small-molecule inhibitors of these Ech enzymes can in future provide the means to specifically target Mtb residing in these lipid-rich environments.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of Proteins Primers and expression vectors used are listed in Table S1 . The Mtb FadB and EchA5 mutants were constructed using QuikChange site-directed mutagenesis kit XL (Stratagene) and mutagenic primers (Table S2) , and confirmed by automated DNA sequencing. The proteins were purified to homogeneity by Ni +2 -nitrilotriacetic acid affinity chromatography. Details are provided in Supplemental Experimental Procedures.
Genetic Reconstitution Screen
Mutant DfadAB E. coli was generated as described in Supplemental Experimental Procedures. E. coli screen was followed in M9 minimal medium supplemented with either 2% glucose, 0.5% sodium acetate, or 0.1% fatty acid. Sodium salt of fatty acid was dissolved in sterile water. Details are provided in Supplemental Experimental Procedures.
Biochemical Assay 3-cis octenoyl CoA, 3-trans octenoyl CoA, and 2-trans Octenoyl CoA were chemically synthesized. For enzymatic assays with purified FadB and Ech proteins (5 mM), 3-cis octenoyl CoA/3-trans octenoyl CoA (200 mM) were incubated at 30 C for 20 min. The reaction was quenched and analyzed by liquid chromatography-MS. In vitro enzymatic assay for purified FadAB complex involved incubation of 5 mM protein complex with 300 mM crotonyl CoA, 300 mM NAD + , and 300 mM CoA at 30 C for 60 min. The reaction was quenched and analyzed by time-of-flight MS (Triple TOF 5600; ABiSciex). For further details, see Supplemental Experimental Procedures.
Computational Modeling for Ligand Binding to Mtb FadB
We used Autodock 4.0 (Morris et al., 2009 ) to conduct molecular docking of FadB in the presence of two ligands, namely 3-cis octenoyl CoA and 3-trans octenoyl CoA. Atomic coordinates of the Mtb FadB crystal structure in presence of the CoA ligand were obtained from the PDB (PDB: 4B3I). For further details, see Supplemental Experimental Procedures.
Oleic Acid Adaptation and Transcriptional Profiling in Mtb
To generate an oleic acid-adapted strain, Mtb H37Rv was grown in 7H9 medium supplemented with 0.1% oleic acid as the major carbon source with 1% oleic acid dextrose catalase and 0.05% Tween 80. Cultures grown in 7H9 supplemented with 10% ADC and 0.05% Tween 80 were considered as control. RNA was isolated and real-time qRT-PCR was performed from three biological replicates. For further details, see Supplemental Experimental Procedures. 
Mtb EchA5 Msmeg_3139
Wavelength λ (Å) B. Crystalloraphic table defining data collection and refinement statistics during the structure solution of Mtb EchA5 and Msmeg_3139. R work = Σ hkl |(|F obs |-|F calc |)|/ Σ hkl |F obs |, where F obs and F calc are the observed and calculated structure-factor amplitudes, respectively. R free is equivalent to R work but calculated using 5% of the total reflections which were chosen randomly in thin resolution shells and omitted from refinement for crossvalidation purposes.
C. Structure of Mtb EchA5 with marked E110, E121 and E122 residues.
D. FPLC chromatogram overlay for gel filtration analysis of EchA5 (yellow) and EchA5 E110A mutant (red). 
SUPPLEMENTAL TABLE
SUPPLEMENTAL EXPERIMENTAL PROCEDURE
Cloning, expression and purification of protein: Mtb genes were PCR amplified from Mycobacterium tuberculosis H37Rv BAC library while Msmeg_3139, Yeast eci1 and E. coli genes were cloned from the genomic DNA of M. smegmatis mc2, S. cerevisae and E. coli BL21 respectively. The primer sequences are provided in Table S1 . To facilitate co-expression of proteins, the desired genes were cloned in pETDuet or pRSFDuet vector (novagen). fadA and fadB genes were cloned in MCS1 and MCS2 respectively of pETDuet vector. While Yeast eci1 and Mtb ech genes were cloned in either MCS1 or MCS2 of pRSFDuet vector as mentioned in Table S1 . For purification of his-tagged protein of Mtb FadB, E. coli FadB, Mtb EchA7, Mtb EchA8, Mtb EchA9 and Msmeg_3139, genes were also cloned in pET21c and pET28c. The Mtb FadB and EchA5 mutant proteins were constructed in accordance with the manufacturer's protocol using Quick Change site-directed mutagenesis kit XL (Stratagene). All proteins were expressed in E. coli BL21 DE3 in soluble form by induction with IPTG either at 37 ο C or lower temperature. The proteins were purified to homogeneity by Ni 2+ -NTA affinity chromatography owing to their N or C terminal his-tag. Gel filtration chromatography was done using Superdex 200 HR column obtained from GE Healthcare Life Sciences. 
